In a study of 9 patients with advanced NSCLC, [18F]BMS-986192 uptake, measured with PET/CT at 1 hr post-injection, was heterogeneous with higher median SUVpeak in patients with high PD-L1 TPS ≥ 50% (p = 0.018) [26]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.